Nycomed JV Opens API Facility in India

Nycomed (Zurich, Switzerland) says its Zydus Nycomed (Navi Mumbai, India) joint venture with Zydus Cadila (Ahmedabad, India) has commissioned its expanded active pharmaceutical ingredients (API) manufacturing facility at Navi Mumbai, and the company is expected to start commercial production of APIs by December. The plant will initially manufacture pantoprazole, urapidil and lornoxicam, and by 2011 it will produce eight additional APIs. Zydus Nycomed is a 50-50 jv, which was formed in 1998. Nycomed had announced in 2008 that it plans to transfer production of...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers